Uncategorized

Uncategorized

New Releases from NCBI BookshelfTesting a Shared Decision-Making Program for Patients with a Canceled or Delayed Screening Colonoscopy during the COVID-19 Pandemic — The PRIMED Study [Internet].​Testing a Shared Decision-Making Program for Patients with a Canceled or Delayed Screening Colonoscopy during the COVID-19 Pandemic — The PRIMED Study [Internet].

Thousands of colonoscopies were canceled or postponed during the initial surge of the COVID-19 pandemic. As facilities resumed services, it

Uncategorized

New Releases from NCBI BookshelfBeyond Diabetes, Obesity, and Cardiovascular Disease: An Evidence Map of Anti-Inflammatory Diet and Related Dietary Interventions for the Prevention and Management of Chronic Health Conditions.​Beyond Diabetes, Obesity, and Cardiovascular Disease: An Evidence Map of Anti-Inflammatory Diet and Related Dietary Interventions for the Prevention and Management of Chronic Health Conditions.

The aim of this synthesis is to develop evidence maps that provide a visual overview of the distribution of evidence

Uncategorized

New Releases from NCBI BookshelfEvaluation of parenting interventions for those with additional health and social care needs during pregnancy: THRIVE a multi-arm RCT with embedded economic and process components.​Evaluation of parenting interventions for those with additional health and social care needs during pregnancy: THRIVE a multi-arm RCT with embedded economic and process components.

Women who have additional social and care needs in pregnancy (e.g. social adversity, maternal depression and anxiety) are likely to

Uncategorized

New Releases from NCBI BookshelfClinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial.​Clinical and cost-effectiveness of lithium versus quetiapine augmentation for treatment-resistant depression in adults: LQD a pragmatic randomised controlled trial.

Lithium and several atypical antipsychotics are the recommended first-line augmentation options for treatment-resistant depression; however, few studies have compared them

Scroll to Top